Around the Net
23Andme Sells Rights To Its First New Drug
- The Verge, Monday, January 13, 2020 12:53 PM
Using the genetic information it collects from customers, testing company 23andMe says it has developed its first drug, and that it is selling the rights to the medication to a Spanish pharmaceutical company. It already shares its data with drug makers, including GlaxoSmithKline.
